PillRx only · Injection, Solution · Intravenous
Sodium Phosphate, Monobasic, Monohydrate And Sodium Phosphate, Dibasic, Anhydrous
Sodium Phosphate, Dibasic, Anhydrous + Sodium Phosphate, Monobasic, Monohydrate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)235496
US makers4 labelers
Packages8
DEA / ScheduleNone
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
9.6K
Rx · 2026 Q1
296K
Units dispensed
+10%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| American Regent, Inc. | unknown | 3 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 3 | SUPPLYING |
| Civica, Inc. | unknown | 1 | SUPPLYING |
| Hospira, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.